KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 173 filers reported holding KARUNA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,300 | -42.8% | 55 | -26.7% | 0.01% | -33.3% |
| Q2 2023 | $16,264 | +19.4% | 75 | 0.0% | 0.01% | +9.1% |
| Q1 2023 | $13,623 | -7.6% | 75 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $14,738 | -13.3% | 75 | 0.0% | 0.01% | -26.7% |
| Q3 2022 | $17,000 | +88.9% | 75 | 0.0% | 0.02% | +114.3% |
| Q2 2022 | $9,000 | -10.0% | 75 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $10,000 | 0.0% | 75 | 0.0% | 0.01% | +16.7% |
| Q4 2021 | $10,000 | -60.0% | 75 | -63.4% | 0.01% | -66.7% |
| Q3 2021 | $25,000 | +19.0% | 205 | +9.6% | 0.02% | +20.0% |
| Q2 2021 | $21,000 | +5.0% | 187 | +10.0% | 0.02% | -6.2% |
| Q1 2021 | $20,000 | – | 170 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |